HistologiX
A UK-based GLP/GCP-compliant contract research organisation specialising in tissue-based biomarker analysis. Services include histology, immunohistochemistry, immunofluorescence, in situ hybridization, digital slide scanning and quantitative image analysis, GLP tissue cross-reactivity studies, and support for preclinical toxicology and clinical trial sample workflows. The organisation operates an HTA-licensed biobank and provides pathology review from board-certified medical and veterinary pathologists.
Industries
Nr. of Employees
small (1-50)
HistologiX
Services
Comprehensive histology services including sample preparation, embedding, sectioning, and a wide range of special stains for research, preclinical and clinical studies.
Chromogenic and immunofluorescent assay development and execution, antibody sourcing, assay transfer and optimisation, and pathology-led interpretation.
High-throughput slide scanning, secure image storage, quantitative image analysis and spatial profiling to generate reproducible endpoints for research and regulatory studies.
GLP-compliant regulatory tissue screening of biologics using optimised IHC assays and pathology reads to assess off-target binding for IND/CTA submissions.
Assay validation on human tissue, sample handling SOPs, site training, biopsy kit preparation, and pathology and image analysis support for trial endpoints.
Optimised IHC/IF assays for assessing tumour microenvironment, immune cell phenotyping and spatial distribution analyses to inform immunotherapeutic strategies.
Comprehensive histology services including sample preparation, embedding, sectioning, and a wide range of special stains for research, preclinical and clinical studies.
Chromogenic and immunofluorescent assay development and execution, antibody sourcing, assay transfer and optimisation, and pathology-led interpretation.
High-throughput slide scanning, secure image storage, quantitative image analysis and spatial profiling to generate reproducible endpoints for research and regulatory studies.
GLP-compliant regulatory tissue screening of biologics using optimised IHC assays and pathology reads to assess off-target binding for IND/CTA submissions.
Assay validation on human tissue, sample handling SOPs, site training, biopsy kit preparation, and pathology and image analysis support for trial endpoints.
Optimised IHC/IF assays for assessing tumour microenvironment, immune cell phenotyping and spatial distribution analyses to inform immunotherapeutic strategies.
Expertise Areas
- Histology and histopathology
- Immunohistochemistry and immunofluorescence assay development
- Digital pathology and quantitative image analysis
- Tissue cross-reactivity studies for biologics
Key Technologies
- Immunohistochemistry
- Immunofluorescence and multiplex IF
- In situ hybridization (RNA detection)
- Whole-slide brightfield and fluorescence scanning
News & Updates
Attendance and exhibition at the BioTrinity conference to discuss tissue-based testing and services.
Announcement of the addition of an AI-driven image analysis platform to augment existing image analysis capabilities.
Article comparing immunohistochemistry and immunofluorescence approaches for research applications.
Awarded ISO 9001:2015 certification for the Quality Management System covering tissue-based pre-clinical and clinical contract research activities.
Attendance and exhibition at the BioTrinity conference to discuss tissue-based testing and services.
Announcement of the addition of an AI-driven image analysis platform to augment existing image analysis capabilities.
Article comparing immunohistochemistry and immunofluorescence approaches for research applications.
Awarded ISO 9001:2015 certification for the Quality Management System covering tissue-based pre-clinical and clinical contract research activities.